Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

 v2.3.0.11
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
 3 Months Ended 6 Months Ended 105 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
COSTS AND EXPENSES:          
Research and development $ 961,953 $ 963,144 $ 1,433,356 $ 2,100,116 $ 18,639,315
General and administrative 796,714 567,226 928,440 923,666 7,898,618
Merger costs 495,773   746,207   799,133
Total costs and expenses 2,254,440 1,530,370 3,108,003 3,023,782 27,337,066
LOSS FROM OPERATIONS (2,254,440) (1,530,370) (3,108,003) (3,023,782) (27,337,066)
OTHER INCOME (EXPENSE):          
Grant income     44,479   244,479
Loss on derivative warrants (70,393)   (70,393)   (70,393)
Interest expense, net (270,378) (91,438) (426,546) (373,852) (443,648)
Other income (expense)       (573) 1,161
Total other expense, net (340,771) (91,438) (452,460) (374,425) (268,401)
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS $ (2,595,211) $ (1,621,808) $ (3,560,463) $ (3,398,207) $ (27,605,467)
BASIC AND DILUTED NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS PER COMMON SHARE $ (0.10) $ (0.13) $ (0.18) $ (0.27) $ (2.74)
SHARES USED IN COMPUTING BASIC AND DILUTED NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS PER COMMON SHARE 25,743,781 12,820,102 19,317,642 12,820,102 10,075,059